TY - JOUR
T1 - FOXA1 protein expression in er+ and er- breast cancer in relation to parity and breastfeeding in black and white women
AU - Cheng, Ting Yuan David
AU - Yao, Song
AU - Omilian, Angela R.
AU - Khoury, Thaer
AU - Buas, Matthew F.
AU - Payne-Ondracek, Rochelle
AU - Sribenja, Sirinapa
AU - Bshara, Wiam
AU - Hong, Chi Chen
AU - Bandera, Elisa V.
AU - Davis, Warren
AU - Higgins, Michael J.
AU - Ambrosone, Christine B.
N1 - Publisher Copyright:
© 2020 American Association for Cancer Research Inc.. All rights reserved.
PY - 2020/2/1
Y1 - 2020/2/1
N2 - Background: Forkhead box protein A1 (FOXA1) promotes luminal differentiation, and hypermethylation of the gene can be a mechanism of developing estrogen receptor negative (ER-) breast cancer. We examined FOXA1 in breast tumor and adjacent normal tissue in relation to reproductive factors, particularly higher parity and no breastfeeding, that are associated with ER- tumors. Methods: Weperformed IHCfor FOXA1 in breast tumors (n1/4 1,329) and adjacent normal tissues (n 1/4 298) in the Women's Circle of Health Study (949 Blacks and 380 Whites). Protein expression levels were summarized by histology (H) scores. Generalized linear models were used to assess FOXA1 protein expression in relation to reproductive factors by ER status. Results: ER-positive (ER ) versus ER- tumors had higher FOXA1 protein expression (P < 0.001). FOXA1 expression was higher in tumor versus paired adjacent normal tissue in women with ER or non-triple negative cancer (both P < 0.001), but not in those with ER- or triple-negative cancer. Higher number of births (1, 2, and 3 ) was associated with lower FOXA1 protein expression in ER tumors [differences in H score, or b 1/4 -8.5; 95% confidence interval (CI), -15.1 to -2.0], particularly among parous women who never breastfed (b1/4-10.4; 95% CI, -19.7 to -1.0), but not among those who breastfed (b 1/4 -7.5; 95% CI, -16.9 to 1.8). The associations for ER- tumors were similar, although they were not statistically significant. Conclusions: In this tumor-based study, higher parity was associated with lower FOXA1 expression in ER tumors, and breastfeeding may ameliorate the influence. Impact: These findings contribute to our understanding of FOXA1 methylation and breast cancer etiology.
AB - Background: Forkhead box protein A1 (FOXA1) promotes luminal differentiation, and hypermethylation of the gene can be a mechanism of developing estrogen receptor negative (ER-) breast cancer. We examined FOXA1 in breast tumor and adjacent normal tissue in relation to reproductive factors, particularly higher parity and no breastfeeding, that are associated with ER- tumors. Methods: Weperformed IHCfor FOXA1 in breast tumors (n1/4 1,329) and adjacent normal tissues (n 1/4 298) in the Women's Circle of Health Study (949 Blacks and 380 Whites). Protein expression levels were summarized by histology (H) scores. Generalized linear models were used to assess FOXA1 protein expression in relation to reproductive factors by ER status. Results: ER-positive (ER ) versus ER- tumors had higher FOXA1 protein expression (P < 0.001). FOXA1 expression was higher in tumor versus paired adjacent normal tissue in women with ER or non-triple negative cancer (both P < 0.001), but not in those with ER- or triple-negative cancer. Higher number of births (1, 2, and 3 ) was associated with lower FOXA1 protein expression in ER tumors [differences in H score, or b 1/4 -8.5; 95% confidence interval (CI), -15.1 to -2.0], particularly among parous women who never breastfed (b1/4-10.4; 95% CI, -19.7 to -1.0), but not among those who breastfed (b 1/4 -7.5; 95% CI, -16.9 to 1.8). The associations for ER- tumors were similar, although they were not statistically significant. Conclusions: In this tumor-based study, higher parity was associated with lower FOXA1 expression in ER tumors, and breastfeeding may ameliorate the influence. Impact: These findings contribute to our understanding of FOXA1 methylation and breast cancer etiology.
UR - http://www.scopus.com/inward/record.url?scp=85079078246&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85079078246&partnerID=8YFLogxK
U2 - 10.1158/1055-9965.EPI-19-0787
DO - 10.1158/1055-9965.EPI-19-0787
M3 - Article
C2 - 31871111
AN - SCOPUS:85079078246
SN - 1055-9965
VL - 29
SP - 379
EP - 385
JO - Cancer Epidemiology Biomarkers and Prevention
JF - Cancer Epidemiology Biomarkers and Prevention
IS - 2
ER -